PDGFRB and Alzheimer disease: PDGFRβ, BCL6, DDIT4L, and TMEM106A each play distinct yet interrelated roles in maintaining central nervous system homeostasis, regulating immune responses, and mediating inflammatory processes, all of which are crucial for elucidating the pathophysiology of AD and CD.